Your browser doesn't support javascript.
loading
Excellent Response to Atezolizumab After Clinically Defined Hyperprogression Upon Previous Treatment With Pembrolizumab in Metastatic Triple-Negative Breast Cancer: A Case Report and Review of the Literature.
Feng, Dongfeng; Guan, Yaping; Liu, Mingguo; He, Shuqian; Zhao, Weipeng; Yin, Beibei; Liang, Jing; Li, Yan; Wang, Jun.
Affiliation
  • Feng D; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Guan Y; Shandong Lung Cancer Institute, Jinan, China.
  • Liu M; Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, China.
  • He S; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Zhao W; Shandong Lung Cancer Institute, Jinan, China.
  • Yin B; Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, China.
  • Liang J; Department of Oncology, Yuncheng Honesty Hospital, Heze, China.
  • Li Y; Department of Pathology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Wang J; Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Front Immunol ; 12: 608292, 2021.
Article in En | MEDLINE | ID: mdl-34135884
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Ductal / Antibodies, Monoclonal, Humanized / Triple Negative Breast Neoplasms / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Immunotherapy Limits: Aged / Female / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Ductal / Antibodies, Monoclonal, Humanized / Triple Negative Breast Neoplasms / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Immunotherapy Limits: Aged / Female / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland